Path Therapeutics
Path Therapeutics' proprietary phenotypic-screening technology is uncovering new therapeutics and novel druggable targets for diseases of the central nervous system, including rare and devastating genetic forms of childhood epilepsy.
Path Therapeutics Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.
Typical time on-site:
Not Specified
Alberta, CAN
